On 2025-05-08, AbCellera Biologics Inc. (ABCL) announced earnings per share of $-0.15 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.17.
The next expected annoucement date for quarterly earnings is 2025-08-05, with an average estimated earnings per share of $-0.17 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.17 | $-0.15 |
| 2025-02-27 | 2024-12-31 | $-0.15 | $-0.11 |
| 2024-11-04 | 2024-09-30 | $-0.14 | $-0.17 |
| 2024-08-06 | 2024-06-30 | $-0.15 | $-0.13 |
| 2024-05-07 | 2024-03-31 | $-0.16 | $-0.14 |
| 2024-02-20 | 2023-12-31 | $-0.14 | $-0.17 |
| 2023-11-02 | 2023-09-30 | $-0.14 | $-0.10 |
| 2023-08-03 | 2023-06-30 | $-0.13 | $-0.11 |
| 2023-05-04 | 2023-03-31 | $-0.12 | $-0.14 |
| 2023-02-21 | 2022-12-31 | $0.01 | $-0.10 |
| 2022-11-08 | 2022-09-30 | $0.09 | $0.08 |
| 2022-08-09 | 2022-06-30 | $0.04 | $-0.02 |
| 2022-05-10 | 2022-03-31 | $0.47 | $0.54 |
| 2022-02-24 | 2021-12-31 | $0.21 | $0.19 |
| 2021-11-09 | 2021-09-30 | $-0.05 | $-0.08 |
| 2021-08-12 | 2021-06-30 | $0.09 | $-0.01 |
| 2021-05-13 | 2021-03-31 | $0.37 | $0.37 |